Yasuko Arao
Suita, 5650871, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Targeting fibroblast activation protein in solid tumors via LNP-mediated CAR-mRNA delivery promotes durable regression in murine models.
Journal: Scientific reports
Published: August 30, 2025
RNA methyltransferase 3 drives pancreatic acinar cell carcinoma growth and is a therapeutic target.
Journal: Signal transduction and targeted therapy
Published: August 07, 2025
Recent Findings in N6-Methyladenosine Modification and Significance in Pancreatic Cancer.
Journal: Cancer medicine
Published: February 12, 2025
In Vivo Engineered CAR-T Cell Therapy: Lessons Built from COVID-19 mRNA Vaccines.
Journal: International journal of molecular sciences
Published: February 11, 2025
Recent Exploration of Solid Cancer Biomarkers Hidden Within Urine or Blood Exosomes That Provide Fundamental Information for Future Cancer Diagnostics.
Journal: Diagnostics (Basel, Switzerland)
Published: December 30, 2024
Non-Invasive Detection of Tumors by Volatile Organic Compounds in Urine.
Journal: Biomedicines
Published: December 16, 2024
Antisense oligonucleotide targeting nicotinamide N-methyltransferase exhibits antitumor effects.
Journal: Molecular therapy. Nucleic acids
Published: November 11, 2024
Recent advances in noncoding RNA modifications of gastrointestinal cancer.
Journal: Cancer science
Published: July 31, 2024
RN7SL1 may be translated under oncogenic conditions.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 13, 2024
High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker.
Journal: Cancer science
Published: December 05, 2023
Last Updated: 09/26/2026